Braillon A, Calès P, Girod C, Lebrec D
J Hepatol. 1986;2(2):267-75. doi: 10.1016/s0168-8278(86)80086-1.
The acute effects of 2 doses of the beta-agonist dobutamine on systemic and splanchnic haemodynamics were studied in normal rats and in rats with portal hypertension due to portal vein stenosis. Cardiac output and splanchnic organ blood flow were estimated with the radioactive microsphere method and portal pressure was measured. Low dose (5 micrograms/kg) of dobutamine did not change significantly arterial pressure and portal pressure but, cardiac output was significantly higher after dobutamine than after placebo in both groups of rats. Similar results were observed with 15 micrograms/kg of dobutamine except for a significant decrease in arterial pressure in portal-hypertensive rats. In sham-operated rats, dobutamine significantly increased portal tributary blood flow; this rise was parallel to cardiac output. In contrast, in portal-hypertensive rats, portal tributary blood flow did not change significantly after dobutamine. Accordingly in the former group, portal tributary vascular resistance significantly decreased, whereas in the latter group, no change in this resistance was observed with a low dose and a significant decrease was noted with a high dose. In both groups of rats, hepatic arterial blood flow was not significantly different after dobutamine than after placebo. This study demonstrates that the vasodilatory response of the portal tributary vascular bed to an increase in cardiac output is altered in anaesthetized rats with portal hypertension due to portal vein stenosis.
研究了两剂β受体激动剂多巴酚丁胺对正常大鼠和门静脉狭窄所致门静脉高压大鼠全身及内脏血流动力学的急性影响。采用放射性微球法估算心输出量和内脏器官血流量,并测量门静脉压力。低剂量(5微克/千克)的多巴酚丁胺对动脉压和门静脉压无显著影响,但两组大鼠使用多巴酚丁胺后的心输出量均显著高于使用安慰剂后。使用15微克/千克的多巴酚丁胺也观察到了类似结果,但门静脉高压大鼠的动脉压显著下降。在假手术大鼠中,多巴酚丁胺显著增加门静脉分支血流量;这种增加与心输出量平行。相比之下,在门静脉高压大鼠中,使用多巴酚丁胺后门静脉分支血流量无显著变化。因此,在前一组中,门静脉分支血管阻力显著降低,而在后一组中,低剂量时该阻力无变化,高剂量时显著降低。两组大鼠使用多巴酚丁胺后的肝动脉血流量与使用安慰剂后相比无显著差异。本研究表明,在因门静脉狭窄导致门静脉高压的麻醉大鼠中,门静脉分支血管床对心输出量增加的血管舒张反应发生了改变。